|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$35,000
|
N/A
|
National Cancer Institute
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,042,262
|
$1,042,262
|
Alter
|
DCEG (NCI)
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-07
|
$5,725,544
|
$3,206,305
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$279,762
|
$139,881
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$279,762
|
$139,881
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$279,762
|
$111,905
|
Aplan, Peter
|
CCR (NCI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-05
|
$256,197
|
$256,197
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$72,399
|
$14,480
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$506,790
|
$202,716
|
Arthur, Diane
|
CCR (NCI)
|
|
Oncogenic NOTCH Signaling
|
5P01CA119070-04
|
$1,012,243
|
$415,020
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
7R01CA112530-04
|
$501,100
|
$250,550
|
BAKER, KEVIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
$20,702
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-31
|
$223,195
|
$33,479
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04020
|
$2,310
|
$577
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04033
|
$172,949
|
$172,949
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04122
|
$194,069
|
$194,069
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10481
|
$32,787
|
$26,229
|
Berrington, Amy
|
DCEG (NCI)
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$167,837
|
$16,784
|
Bishop, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B - The Ohio State University
|
2U10CA077658-12
|
$494,501
|
$29,670
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Genetic Consequences of Therapies for Cancer
|
5R01CA104666-05
|
$573,425
|
$573,425
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-09
|
$561,044
|
$561,044
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing FLT3-Targeted Therapy for Pediatric Leukemia
|
5K23CA111728-04
|
$140,130
|
$70,065
|
BROWN, PATRICK
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting MLL As Anticancer Therapy for Infant Acute Lymphoblastic Leukemia
|
1R43CA141903-01
|
$130,694
|
$130,694
|
Burkhart, Catherine
|
BUFFALO BIOLABS, LLC
|
|
Investigating the role of retrotransposons in hematopoietic neoplasias.
|
5K08CA134746-02
|
$139,725
|
$34,931
|
BURNS, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer and Leukemia Group B
|
2U10CA032291-28
|
$413,820
|
$24,829
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
2U10CA101140-07
|
$861,611
|
$51,697
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cell Therapy of Refractory Leukemia
|
5R01CA113482-04
|
$289,553
|
$144,777
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Significance of Residual Myeloid Leukemia
|
5R01CA115422-04
|
$260,597
|
$130,299
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Role of PBX Proteins in Hematopoiesis and Growth Control
|
5R01CA090735-09
|
$300,009
|
$300,009
|
CLEARY, MICHAEL
|
STANFORD UNIVERSITY
|
|
Physical Activity to Modify Sequelae and QOL in Childhood ALL: A Nursing Trial
|
1R01CA129384-01A2
|
$1,023,985
|
$1,023,985
|
COX, CHERYL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer and Leukemia Group B
|
2U10CA047577-22
|
$157,170
|
$9,430
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
5R01CA101774-07
|
$305,363
|
$305,363
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY
|
|
Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia
|
1P01CA129242-01A2
|
$1,011,385
|
$1,011,385
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Role of miR155 in Leukemogenesis
|
5R01CA124541-02
|
$330,797
|
$165,399
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
|
3P30CA013696-36S1
|
$99,928
|
$1,999
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-36
|
$3,999,822
|
$79,996
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Molecular genetics of MLL-associated leukemia
|
5P01CA105049-05
|
$1,210,621
|
$605,311
|
DIAZ, MANUEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
5R01CA119162-03
|
$90,274
|
$90,274
|
Drotar, Dennis
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Identifying genetic mechanisms in T-ALL with an inducible Sleeping Beauty system
|
5R01CA130867-02
|
$311,250
|
$311,250
|
Dupuy, Adam
|
UNIVERSITY OF IOWA
|
|
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
|
5R37CA036401-26
|
$590,109
|
$590,109
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Risk Factors for TEL-AML Fusion Genes and Childhood Acute Lymphoblastic Leukemia
|
5R03CA133960-02
|
$54,000
|
$54,000
|
Ezzat, Sameera
|
NATL HEPATOLOGY/TROPICAL MED RES INST
|
|
Mechanisms of T-Cell Leukemogenesis Induced by Notch1
|
5R01CA120196-03
|
$305,900
|
$152,950
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of AKT signaling in NOTCH1 induced leukemias
|
5R01CA129382-02
|
$341,043
|
$170,522
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA033572-26S1
|
$94,753
|
$3,790
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-26S2
|
$107,415
|
$4,297
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-26S3
|
$100,000
|
$4,000
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
Total relevant funding to Childhood Leukemia for this search: $47,255,992
|